tiprankstipranks
Advertisement
Advertisement
Ascendis Pharma Strikes Global Settlement and Licensing Deal With BioMarin Over YUVIWEL
PremiumCompany AnnouncementsAscendis Pharma Strikes Global Settlement and Licensing Deal With BioMarin Over YUVIWEL
6d ago
H.C. Wainwright trims Ascendis target, says litigation overhang removed
Premium
The Fly
H.C. Wainwright trims Ascendis target, says litigation overhang removed
6d ago
BioMarin price target raised to $105 from $104 at Jefferies
Premium
The Fly
BioMarin price target raised to $105 from $104 at Jefferies
6d ago
Ascendis Pharma price target lowered to $304 from $306 at BofA
PremiumThe FlyAscendis Pharma price target lowered to $304 from $306 at BofA
6d ago
Ascendis Pharma price target lowered to $330 from $333 at Jefferies
Premium
The Fly
Ascendis Pharma price target lowered to $330 from $333 at Jefferies
6d ago
Ascendis Pharma price target lowered to $326 from $328 at Stifel
Premium
The Fly
Ascendis Pharma price target lowered to $326 from $328 at Stifel
6d ago
Ascendis Pharma initiated with a Buy at H.C. Wainwright
PremiumThe FlyAscendis Pharma initiated with a Buy at H.C. Wainwright
10d ago
Ascendis Pharma Earnings Call Highlights Blockbuster Momentum
Premium
Company Announcements
Ascendis Pharma Earnings Call Highlights Blockbuster Momentum
13d ago
BMO starts Ascendis at Outperform on further platform growth
Premium
The Fly
BMO starts Ascendis at Outperform on further platform growth
19d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100